Form 483

McPherson Enterprises, Inc., dba Implantable Devices Form 483, 2012-10-29

FDA issued a Form 483 to McPherson Enterprises, Inc., dba Implantable Devices on 2012-10-29 with 5 public-safe observations.

483· Form 483 issued5 observations

McPherson Enterprises, Inc., dba Implantable Devices · Pinellas Park, United States · Issued October 29, 2012

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Oct 2012
21 CFR 820.70(b)

Production and Process Change Procedures, lack of or Inad.

Cited by Joshua J Silvestri

29 Oct 2012
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Joshua J Silvestri

29 Oct 2012
21 CFR 820.75(b)

Lack/Inad procedure-Monitoring/Control of Validated Proces

Cited by Joshua J Silvestri

29 Oct 2012
21 CFR 820.80(d)

Lack of or inadequate final acceptance procedures

Cited by Joshua J Silvestri

29 Oct 2012
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Joshua J Silvestri

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.70(b)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(b)Cited across public-safe Form 483 observations1x
21 CFR 820.80(d)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere